Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease
Background: Contrast-induced acute kidney injury (CIAKI) following coronary angiography is frequently observed in the general population. End-stage liver disease (ESLD) patients are at a particularly increased risk for development of CIAKI following coronary angiography due to preexisting renal hypo...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-09-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2019.1661148 |
id |
doaj-4664c65225cf4b4abae89aed01c71b98 |
---|---|
record_format |
Article |
spelling |
doaj-4664c65225cf4b4abae89aed01c71b982020-11-25T01:54:28ZengTaylor & Francis GroupJournal of Community Hospital Internal Medicine Perspectives2000-96662019-09-019540340910.1080/20009666.2019.16611481661148Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver diseasePriyanka Bhandari0Zeel Shah1Kush Patel2Ruchir Patel3Mount Sinai Elmhurst HospitalMount Sinai Elmhurst HospitalSouthside Northwell HospitalHenry Ford HospitalBackground: Contrast-induced acute kidney injury (CIAKI) following coronary angiography is frequently observed in the general population. End-stage liver disease (ESLD) patients are at a particularly increased risk for development of CIAKI following coronary angiography due to preexisting renal hypoperfusion. Methods: We performed a retrospective study of 544 consecutive cardiac catheterizations in ESLD patients from December 2003 to May 2013 to calculate the incidence of CIAKI post-coronary angiography and to identify risk factors for CIAKI. CIAKI was defined as a serum creatinine increase of either ≥ 25% or ≥ 0.5 mg/dL from baseline within 72 hours. Multivariable and Cox regression analysis was performed for development of CIAKI and all-cause mortality, respectively. Results: Overall, 179 cases of coronary angiography were included in the final analysis. CIAKI occurred in 23% of patients. All-cause mortality was 52% in the CIAKI group and 37% in the non-CIAKI group, with a mean follow-up of 2.2 ± 3.8 years. Multivariable analysis identified intensive care unit admission (OR 2.72, CI 1.05–7.01, p < 0.05) and baseline estimated glomerular filtration rate (OR 1.02, CI 1.002–1.035, p < 0.05) as independent predictors of CIAKI. Cox regression analysis identified pre-angiography beta-blocker use (HR 2.13, CI 1.04–4.38, p < 0.05), international normalized ratio (HR 1.37, CI 1.05–1.78, p < 0.05) and Mehran risk score (HR 1.13, CI 1.02–1.25, p < 0.05) as independent predictors of all-cause mortality. Conclusions: CIAKI in ESLD patients undergoing coronary angiography occurs at a moderately elevated rate when compared to the general population.http://dx.doi.org/10.1080/20009666.2019.1661148contrast-induced acute kidney injurycontrast nephropathycoronary angiographymortalityoutcomescirrhosisend-stage liver disease |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Priyanka Bhandari Zeel Shah Kush Patel Ruchir Patel |
spellingShingle |
Priyanka Bhandari Zeel Shah Kush Patel Ruchir Patel Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease Journal of Community Hospital Internal Medicine Perspectives contrast-induced acute kidney injury contrast nephropathy coronary angiography mortality outcomes cirrhosis end-stage liver disease |
author_facet |
Priyanka Bhandari Zeel Shah Kush Patel Ruchir Patel |
author_sort |
Priyanka Bhandari |
title |
Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease |
title_short |
Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease |
title_full |
Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease |
title_fullStr |
Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease |
title_full_unstemmed |
Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease |
title_sort |
contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease |
publisher |
Taylor & Francis Group |
series |
Journal of Community Hospital Internal Medicine Perspectives |
issn |
2000-9666 |
publishDate |
2019-09-01 |
description |
Background: Contrast-induced acute kidney injury (CIAKI) following coronary angiography is frequently observed in the general population. End-stage liver disease (ESLD) patients are at a particularly increased risk for development of CIAKI following coronary angiography due to preexisting renal hypoperfusion. Methods: We performed a retrospective study of 544 consecutive cardiac catheterizations in ESLD patients from December 2003 to May 2013 to calculate the incidence of CIAKI post-coronary angiography and to identify risk factors for CIAKI. CIAKI was defined as a serum creatinine increase of either ≥ 25% or ≥ 0.5 mg/dL from baseline within 72 hours. Multivariable and Cox regression analysis was performed for development of CIAKI and all-cause mortality, respectively. Results: Overall, 179 cases of coronary angiography were included in the final analysis. CIAKI occurred in 23% of patients. All-cause mortality was 52% in the CIAKI group and 37% in the non-CIAKI group, with a mean follow-up of 2.2 ± 3.8 years. Multivariable analysis identified intensive care unit admission (OR 2.72, CI 1.05–7.01, p < 0.05) and baseline estimated glomerular filtration rate (OR 1.02, CI 1.002–1.035, p < 0.05) as independent predictors of CIAKI. Cox regression analysis identified pre-angiography beta-blocker use (HR 2.13, CI 1.04–4.38, p < 0.05), international normalized ratio (HR 1.37, CI 1.05–1.78, p < 0.05) and Mehran risk score (HR 1.13, CI 1.02–1.25, p < 0.05) as independent predictors of all-cause mortality. Conclusions: CIAKI in ESLD patients undergoing coronary angiography occurs at a moderately elevated rate when compared to the general population. |
topic |
contrast-induced acute kidney injury contrast nephropathy coronary angiography mortality outcomes cirrhosis end-stage liver disease |
url |
http://dx.doi.org/10.1080/20009666.2019.1661148 |
work_keys_str_mv |
AT priyankabhandari contrastinducedacutekidneyinjuryfollowingcoronaryangiographyinpatientswithendstageliverdisease AT zeelshah contrastinducedacutekidneyinjuryfollowingcoronaryangiographyinpatientswithendstageliverdisease AT kushpatel contrastinducedacutekidneyinjuryfollowingcoronaryangiographyinpatientswithendstageliverdisease AT ruchirpatel contrastinducedacutekidneyinjuryfollowingcoronaryangiographyinpatientswithendstageliverdisease |
_version_ |
1724987246756495360 |